Mayo Clinic and Stanford Health's discoveries could shift future clinical decision-making, as advances in artificial intelligence uncover how normal cells in a tumor's spatial environment respond to immunotherapy. For the first time, a blood test can reveal factors in tumor microenvironments across multiple cancer types, and could make precision oncology possible across a multitude of cancer patient populations, Mayo Clinic has announced. A new artificial intelligence framework, developed alongside Stanford Medicine researchers over the past eight years, offers a paradigm shift for clinical decision-making in oncology, according to Dr. Aadel Chaudhuri, a radiation oncologist at Mayo Clinic and professor in…
For the first time, a blood test can reveal factors in tumor microenvironments across multiple cancer types, and could make precision oncology possible across a multitude of cancer patient populations, Mayo Clinic has announced.
A new artificial intelligence framework, developed alongside Stanford Medicine researchers over the past eight years, offers a paradigm shift for clinical decision-making in oncology, according to Dr. Aadel Chaudhuri, a radiation oncologist at Mayo Clinic and professor in the Department of Radiation Oncology.
US Pharma Marketing